SEC Form 4 · accession 0001209191-15-036241
CLEVELAND BIOLABS INC · CBLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yakov Kogan
Officer — Chief Executive Officer · Director
Period of report
Apr 22, 2015
Accepted (ET)
Apr 24, 2015 · 7:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001318641
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $3.20 | Apr 22, 2015 | A | 6,250 | A | Apr 22, 2015 | Apr 22, 2025 | Common Stock | 6,250 | 6,250 | D |
| Stock Option (right to buy)F1 | $3.20 | Apr 22, 2015 | A | 6,250 | A | Apr 22, 2015 | Apr 22, 2025 | Common Stock | 6,250 | 12,500 | I |
Explanation of responses
- F1Leah Brownlee, who was hired as an employee of the Company effective March 1, 2010, is the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, or for any other purpose.